Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals.

Gut. 2016 Sep;65(9):1505-13. doi: 10.1136/gutjnl-2014-308008. Epub 2015 May 18.

PMID:
25986944
2.

High-resolution melting (HRM) re-analysis of a polyposis patients cohort reveals previously undetected heterozygous and mosaic APC gene mutations.

Out AA, van Minderhout IJ, van der Stoep N, van Bommel LS, Kluijt I, Aalfs C, Voorendt M, Vossen RH, Nielsen M, Vasen HF, Morreau H, Devilee P, Tops CM, Hes FJ.

Fam Cancer. 2015 Jun;14(2):247-57. doi: 10.1007/s10689-015-9780-5.

3.

Identification of a Dutch founder mutation in MUSK causing fetal akinesia deformation sequence.

Tan-Sindhunata MB, Mathijssen IB, Smit M, Baas F, de Vries JI, van der Voorn JP, Kluijt I, Hagen MA, Blom EW, Sistermans E, Meijers-Heijboer H, Waisfisz Q, Weiss MM, Groffen AJ.

Eur J Hum Genet. 2015 Sep;23(9):1151-7. doi: 10.1038/ejhg.2014.273. Epub 2014 Dec 24.

4.

Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics.

Eijzenga W, Bleiker EM, Hahn DE, Kluijt I, Sidharta GN, Gundy C, Aaronson NK.

Psychooncology. 2014 Aug;23(8):862-9. doi: 10.1002/pon.3485. Epub 2014 Jan 20.

PMID:
24443031
5.

The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.

Eijzenga W, Aaronson NK, Kluijt I, Sidharta GN, Hahn DE, Ausems MG, Bleiker EM.

BMC Cancer. 2014 Jan 15;14:26. doi: 10.1186/1471-2407-14-26.

6.

Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Eijzenga W, Hahn DE, Aaronson NK, Kluijt I, Bleiker EM.

J Genet Couns. 2014 Apr;23(2):133-46. doi: 10.1007/s10897-013-9649-4. Epub 2013 Aug 31. Review.

PMID:
23996531
7.

An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer.

Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland I, Winter M, Huntsman D, Jonkers J, Bahlo M, Bernards R.

J Pathol. 2013 Mar;229(4):621-9. doi: 10.1002/path.4152.

PMID:
23208944
8.

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.

Canto MI, Harinck F, Hruban RH, Offerhaus GJ, Poley JW, Kamel I, Nio Y, Schulick RS, Bassi C, Kluijt I, Levy MJ, Chak A, Fockens P, Goggins M, Bruno M; International Cancer of Pancreas Screening (CAPS) Consortium.

Gut. 2013 Mar;62(3):339-47. doi: 10.1136/gutjnl-2012-303108. Epub 2012 Nov 7. Erratum in: Gut. 2014 Dec;63(12):1978. Hammell, Pascal [corrected to Hammel, Pascal]. Gut. 2014 Jan;63(1):178. Hamell, Pascal [corrected to Hammell, Pascal].

9.

Risks of less common cancers in proven mutation carriers with lynch syndrome.

Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO, Schmiegel W, Buettner R, Moeslein G, Letteboer TG, Gómez García E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Wagner A, Kluijt I, Propping P, Vasen HF.

J Clin Oncol. 2012 Dec 10;30(35):4409-15. doi: 10.1200/JCO.2012.43.2278. Epub 2012 Oct 22.

PMID:
23091106
10.

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study.

Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H; OCGN, Thomassen M, Paligo M, Aretini P; SWE-BRCA, Kantala J, Aroer B, von Wachenfeldt A, Liljegren A, Loman N, Herbst K, Kristoffersson U, Rosenquist R, Karlsson P, Stenmark-Askmalm M, Melin B, Nathanson KL, Domchek SM, Byrski T, Huzarski T, Gronwald J, Menkiszak J, Cybulski C, Serrano P, Osorio A, Cajal TR, Tsitlaidou M, Benítez J, Gilbert M; HEBON, Rookus M, Aalfs CM, Kluijt I, Boessenkool-Pape JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Blok MJ, Nelen MR, van den Ouweland AM, Seynaeve C, van der Luijt RB, Devilee P; EMBRACE, Easton DF, Peock S, Frost D, Platte R, Ellis SD, Fineberg E, Evans DG, Lalloo F, Eeles R, Jacobs C, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Godwin A, Bove B; GEMO Study Collaborators, Stoppa-Lyonnet D, Caux-Moncoutier V, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Boutry-Kryza N, Pujol P, Coupier I, Peyrat JP, Vennin P, Muller D, Fricker JP, Venat-Bouvet L, Johannsson OT, Isaacs C, Schmutzler R, Wappenschmidt B, Meindl A, Arnold N, Varon-Mateeva R, Niederacher D, Sutter C, Deissler H, Preisler-Adams S, Simard J, Soucy P, Durocher F, Chenevix-Trench G, Beesley J, Chen X; KConFab, Rebbeck T, Couch F, Wang X, Lindor N, Fredericksen Z, Pankratz VS, Peterlongo P, Bonanni B, Fortuzzi S, Peissel B, Szabo C, Mai PL, Loud JT, Lubinski J; CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer.

Br J Cancer. 2012 Jun 5;106(12):2016-24. doi: 10.1038/bjc.2012.160. Epub 2012 May 15.

11.

Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.

Harinck F, Kluijt I, van der Stoep N, Oldenburg RA, Wagner A, Aalfs CM, Sijmons RH, Poley JW, Kuipers EJ, Fockens P, van Os TA, Bruno MJ.

J Med Genet. 2012 Jun;49(6):362-5. doi: 10.1136/jmedgenet-2011-100563. Epub 2012 May 25.

PMID:
22636603
12.

Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.

Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, de Jong D, van Krieken JH, van Hillegersberg R, Ligtenberg M, Bleiker E, Cats A; Dutch Working Group on Hereditary Gastric Cancer.

Fam Cancer. 2012 Sep;11(3):363-9. doi: 10.1007/s10689-012-9521-y.

PMID:
22388873
13.

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.

Harinck F, Kluijt I, van Mil SE, Waisfisz Q, van Os TA, Aalfs CM, Wagner A, Olderode-Berends M, Sijmons RH, Kuipers EJ, Poley JW, Fockens P, Bruno MJ.

Eur J Hum Genet. 2012 May;20(5):577-9. doi: 10.1038/ejhg.2011.226. Epub 2011 Dec 14.

14.

CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.

Adank MA, Jonker MA, Kluijt I, van Mil SE, Oldenburg RA, Mooi WJ, Hogervorst FB, van den Ouweland AM, Gille JJ, Schmidt MK, van der Vaart AW, Meijers-Heijboer H, Waisfisz Q.

J Med Genet. 2011 Dec;48(12):860-3. doi: 10.1136/jmedgenet-2011-100380. Epub 2011 Nov 5.

PMID:
22058428
15.

CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling.

Kluijt I, Siemerink EJ, Ausems MG, van Os TA, de Jong D, Simões-Correia J, van Krieken JH, Ligtenberg MJ, Figueiredo J, van Riel E, Sijmons RH, Plukker JT, van Hillegersberg R, Dekker E, Oliveira C, Cats A, Hoogerbrugge N; Dutch Working Group on Hereditary Gastric Cancer.

Int J Cancer. 2012 Jul 15;131(2):367-76. doi: 10.1002/ijc.26398. Epub 2011 Oct 23.

16.

Feasibility of a pancreatic cancer surveillance program from a psychological point of view.

Harinck F, Nagtegaal T, Kluijt I, Aalfs C, Smets E, Poley JW, Wagner A, van Hooft J, Fockens P, Bruno M, Bleiker EM.

Genet Med. 2011 Dec;13(12):1015-24. doi: 10.1097/GIM.0b013e31822934f5.

PMID:
21857231
17.

Ataxia telangiectasia: the consequences of a delayed diagnosis.

Mandigers CM, van de Warrenburg BP, Strobbe LJ, Kluijt I, Molenaar AH, Schinagl DA.

Radiother Oncol. 2011 Apr;99(1):97-8. doi: 10.1016/j.radonc.2011.02.007. Epub 2011 Feb 26. No abstract available.

PMID:
21354641
18.

[Familial gastric cancer: diagnosis, treatment and periodic surveillance].

Kluijt I, Sijmons RH, Hoogerbrugge N, Vasen HF, Cats A.

Ned Tijdschr Geneeskd. 2011;155:A2731. Review. Dutch.

PMID:
21329544
19.

Birt-Hogg-Dubé Syndrome.

Reese E, Sluzevich J, Kluijt I, Teertstra HJ, De Jong D, Horenblas S, Ryu J.

In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M, editors. Cancer Syndromes [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2009-.
2009 Sep 1 [updated 2009 Oct 5].

20.

Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.

Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ.

Lancet Oncol. 2011 Jan;12(1):49-55. doi: 10.1016/S1470-2045(10)70265-5. Epub 2010 Dec 8.

21.

Is early diagnosis of pancreatic cancer fiction? Surveillance of individuals at high risk for pancreatic cancer.

Harinck F, Poley JW, Kluijt I, Fockens P, Bruno MJ; Dutch Research Group of Pancreatic Cancer Surveillance in High-Risk Individuals.

Dig Dis. 2010;28(4-5):670-8. doi: 10.1159/000320095. Epub 2010 Nov 18.

PMID:
21088419
22.

Gastric adenocarcinoma in a 13-year-old boy: a diagnosis not often seen in this age group.

Raphael MF, Kluijt I, Koot BG, Smets AM, Tilanus ME, Bras J, van de Wetering MD.

Pediatr Hematol Oncol. 2011 Feb;28(1):71-7. doi: 10.3109/08880018.2010.520820. Epub 2010 Nov 17.

PMID:
21083354
23.

Body weight and risk of breast cancer in BRCA1/2 mutation carriers.

Manders P, Pijpe A, Hooning MJ, Kluijt I, Vasen HF, Hoogerbrugge N, van Asperen CJ, Meijers-Heijboer H, Ausems MG, van Os TA, Gomez-Garcia EB, Brohet RM; HEBON, van Leeuwen FE, Rookus MA.

Breast Cancer Res Treat. 2011 Feb;126(1):193-202. doi: 10.1007/s10549-010-1120-8. Epub 2010 Aug 21.

PMID:
20730487
24.

A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome.

van Riel E, Ausems MG, Hogervorst FB, Kluijt I, van Gijn ME, van Echtelt J, Scheidel-Jacobse K, Hennekam EF, Stulp RP, Vos YJ, Offerhaus GJ, Menko FH, Gille JJ.

Hered Cancer Clin Pract. 2010 Aug 12;8(1):7. doi: 10.1186/1897-4287-8-7.

25.

Surveillance in individuals at high risk of pancreatic cancer: too early to tell?

Harinck F, Canto MI, Schulick R, Goggins M, Poley JW, Fockens P, Kluijt I, Bruno M.

Gut. 2010 Jul;59(7):1005; author reply 1006-7. doi: 10.1136/gut.2009.197004. No abstract available.

PMID:
20581252
26.

Hereditary causes of kidney tumours.

Axwijk PH, Kluijt I, de Jong D, Gille H, Teertstra J, Horenblas S.

Eur J Clin Invest. 2010 May;40(5):433-9. doi: 10.1111/j.1365-2362.2010.02270.x. Review.

PMID:
20534065
27.

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.

Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van 't Veer LJ.

J Med Genet. 2010 Jun;47(6):421-8. doi: 10.1136/jmg.2009.073429.

PMID:
20522432
28.

Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.

Lammens CR, Aaronson NK, Wagner A, Sijmons RH, Ausems MG, Vriends AH, Ruijs MW, van Os TA, Spruijt L, Gómez García EB, Kluijt I, Nagtegaal T, Verhoef S, Bleiker EM.

J Clin Oncol. 2010 Jun 20;28(18):3008-14. doi: 10.1200/JCO.2009.27.2112. Epub 2010 May 17.

PMID:
20479422
29.

The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.

Poley JW, Kluijt I, Gouma DJ, Harinck F, Wagner A, Aalfs C, van Eijck CH, Cats A, Kuipers EJ, Nio Y, Fockens P, Bruno MJ.

Am J Gastroenterol. 2009 Sep;104(9):2175-81. doi: 10.1038/ajg.2009.276. Epub 2009 Jun 2.

PMID:
19491823
30.

Atypical familial presentation of FAMMM syndrome with a high incidence of pancreatic cancer: case finding of asymptomatic individuals by EUS surveillance.

Kluijt I, Cats A, Fockens P, Nio Y, Gouma DJ, Bruno MJ.

J Clin Gastroenterol. 2009 Oct;43(9):853-7. doi: 10.1097/MCG.0b013e3181981123.

PMID:
19417680
31.

Early onset of renal cancer in a family with Birt-Hogg-Dubé syndrome.

Kluijt I, de Jong D, Teertstra HJ, Axwijk PH, Gille JJ, Bell K, van Rens A, van der Velden AW, Middelton L, Horenblas S.

Clin Genet. 2009 Jun;75(6):537-43. doi: 10.1111/j.1399-0004.2009.01159.x. Epub 2009 Mar 23.

PMID:
19320655
32.

Colorectal cancer in the family: psychosocial distress and social issues in the years following genetic counselling.

Bleiker EM, Menko FH, Kluijt I, Taal BG, Gerritsma MA, Wever LD, Aaronson NK.

Hered Cancer Clin Pract. 2007 Jun 15;5(2):59-66. doi: 10.1186/1897-4287-5-2-59.

33.

Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS).

Andrieu N, Goldgar DE, Easton DF, Rookus M, Brohet R, Antoniou AC, Peock S, Evans G, Eccles D, Douglas F, Noguès C, Gauthier-Villars M, Chompret A, Van Leeuwen FE, Kluijt I, Benitez J, Arver B, Olah E, Chang-Claude J; EMBRACE; GENEPSO; GEO-HEBON; IBCCS Collaborators Group.

J Natl Cancer Inst. 2006 Apr 19;98(8):535-44.

34.

Screening behavior of individuals at high risk for colorectal cancer.

Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, Vasen HF, Aaronson NK.

Gastroenterology. 2005 Feb;128(2):280-7.

PMID:
15685539
35.

Experience of discharge from colonoscopy of mutation negative HNPCC family members.

Bleiker EM, Menko FH, Taal BG, Kluijt I, Wever LD, Gerritsma MA, Vasen HF, Aaronson NK.

J Med Genet. 2003 May;40(5):e55. No abstract available.

36.

Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

Hogervorst FB, Nederlof PM, Gille JJ, McElgunn CJ, Grippeling M, Pruntel R, Regnerus R, van Welsem T, van Spaendonk R, Menko FH, Kluijt I, Dommering C, Verhoef S, Schouten JP, van't Veer LJ, Pals G.

Cancer Res. 2003 Apr 1;63(7):1449-53.

37.

A family with complement factor D deficiency.

Biesma DH, Hannema AJ, van Velzen-Blad H, Mulder L, van Zwieten R, Kluijt I, Roos D.

J Clin Invest. 2001 Jul;108(2):233-40.

38.

Kabuki syndrome - report of six cases and review of the literature with emphasis on ocular features.

Kluijt I, van Dorp DB, Kwee ML, Toutain A, Keppler-Noreuil K, Warburg M, Bitoun P.

Ophthalmic Genet. 2000 Mar;21(1):51-61. Review.

PMID:
10779849
39.

The gene for hypotrichosis of Marie Unna maps between D8S258 and D8S298: exclusion of the hr gene by cDNA and genomic sequencing.

van Steensel M, Smith FJ, Steijlen PM, Kluijt I, Stevens HP, Messenger A, Kremer H, Dunnill MG, Kennedy C, Munro CS, Doherty VR, McGrath JA, Covello SP, Coleman CM, Uitto J, McLean WH.

Am J Hum Genet. 1999 Aug;65(2):413-9.

40.

Ophthalmologic abnormalities in encephalocraniocutaneous lipomatosis.

MacLaren MJ, Kluijt I, Koole FD.

Doc Ophthalmol. 1995;90(1):87-98. Review.

PMID:
8549249

Supplemental Content

Loading ...
Support Center